GYEMSZI - MOB

Bereswill, Stefan - Kapcsolódó tételek

1.			Absinthe against multi-drug resistant bacterial pathogens? : a recent update on the antibacterial effects of Artemisia compounds
2.			Antibacterial effects of biologically active ingredients in hop provide promising options to fight infections by pathogens including multi-drug resistant bacteria
3.			Antibacterial effects of sulforaphane - A phytonutrient derived from broccoli as promising candidate in the combat of bacterial infections
4.			Antibacterial effects of vanilla ingredients provide novel treatment options for infections with multidrug-resistant bacteria - A recent literature review
5.			Antibacterial properties of capsaicin and its derivatives and their potential to fight antibiotic resistance - A literature survey
6.			Anti-inflammatory effects of the octapeptide NAP in human microbiota-associated mice suffering from subacute ileitis
7.			Anti-Inflammatory Properties of NAP in Acute Toxoplasma gondii-Induced Ileitis in Mice
8.			Antimicrobial and Immune-Modulatory Effects of Vitamin D Provide Promising Antibiotics-Independent Approaches to Tackle Bacterial Infections - Lessons Learnt from a Literature Survey
9.			Campylobacter jejuni infection induces acute enterocolitis in IL-10-/- mice pretreated with ampicillin plus sulbactam
10.			Carvacrol prophylaxis improves clinical outcome and dampens apoptotic and pro-inflammatory immune responses upon Campylobacter jejuni infection of human microbiota-associated IL-10-/- mice
11.			Changes of the intestinal microbiome-host homeostasis in HIV-infected individuals - a focus on the bacterial gut microbiome
12.			Colonic Expression of Genes Encoding Inflammatory Mediators and Gelatinases During Campylobacter Jejuni Infection of Conventional Infant Mice
13.			Colonization resistance against genetically modified Escherichia coli K12 (W3110) strains is abrogated following broad-spectrum antibiotic treatment and acute ileitis
14.			Come to the dark side - A review on the health-beneficial and disease-alleviating effects of cocoa-rich dark chocolate
15.			Commensal microbiota drive proliferation of conventional and Foxp3+ Regulatory CD4+ T cells in mesenteric lymph nodes and Peyer's patches
16.			Comprehensive survey of intestinal microbiota changes in offspring of human microbiota associated mice
17.			The conundrum of colonization resistance against Campylobacter reloaded: The gut microbota composition in conventional mice does not prevent from Campylobacter coli infection
18.			Differential antibiosis predisposes mice to Campylobacter jejuni infection: Deeper insights into the impact of the gut microbiota composition in colonization resistance
19.			Dissecting the interplay between intestinal microbiota and host immunity in health and disease: Lessons learned from germfree and gnotobiotic animal models
20.			Distinct antibiotic treatment regimens differentially affect colonization resistance against multi-drug resistant Pseudomonas aeruginosa in mice
21.			Fecal Microbiota Transplantation Decreases Intestinal Loads of Multi-Drug Resistant Pseudomonas aeruginosa in Murine Carriers
22.			Finding novel antibiotic substances from medicinal plants - Antimicrobial properties of Nigella sativa directed against multidrug resistant bacteria
23.			Function of serine protease HtrA in the lifecycle of the foodborne pathogen Campylobacter jejuni
24.			Human microbiota associated IL-10-/- mice: A valuable enterocolitis model to dissect the interactions of Campylobacter jejuni with host immunity and gut microbiota
25.			Immunomodulatory and Antimicrobial Effects of Vitamin C
26.			The impact of ketogenic diet on the onset and progression of multiple sclerosis
27.			Impact of metal ion homeostasis of genetically modified Escherichia coli Nissle 1917 and K12 (W3110) strains on colonization properties in the murine intestinal tract
28.			Infections acquired in barbershops - A review
29.			Intestinal expression of genes encoding inflammatory mediators and gelatinases during Arcobacter butzleri infection of gnotobiotic IL-10 deficient mice
30.			Intestinal microbiota changes in mice lacking pituitary adenylate cyclase activating polypeptide (PACAP) - bifidobacteria make the difference
31.			A literature survey on antimicrobial and immune-modulatory effects of butyrate revealing non-antibiotic approaches to tackle bacterial infections
32.			Matrix Metalloproteinase-2 Mediates Intestinal Immunopathogenesis in Campylobacter jejuni-infected infant mice
33.			Microbiota composition and immune responses during Campylobacter jejuni infection in conventionally colonized IL-10-/- mice lacking nucleotide oligomerization domain 2
34.			Microbiota composition and inflammatory immune responses upon peroral application of the commercial competitive exclusion product Aviguard(R) to microbiota-depleted wildtype mice
35.			Modulation of the intestinal microbiota impacts the efficacy of immunotherapy in cancer patients - A recent literature survey
36.			Multidrug-resistant Pseudomonas aeruginosa induce systemic pro-inflammatory immune responses in colonized mice
37.			Not only for Christmas: Prophylactic oral application of trans-cinnamaldehyde alleviates acute murine campylobacteriosis
38.			Oral application of carvacrol, butyrate, ellagic acid, and 2'-fucosyl-lactose to mice suffering from acute campylobacteriosis - Results from a preclinical placebo-controlled intervention study
39.			Peroral low-dose Toxoplasma gondii infection of human microbiota-associated mice - a subacute ileitis model to unravel pathogen-host interactions
40.			Phage therapy in lung infections caused by multidrug-resistant Pseudomonas aeruginosa - A literature review
41.			Phage therapy in prosthetic joint infections caused by Staphylococcus aureus - A literature review
42.			Polyphenolic compounds in the combat of foodborne infections - An update on recent evidence
43.			Prophylactic oral application of resveratrol to alleviate acute campylobacteriosis in human gut microbiota associated IL-10-/- mice
44.			Recent evidence on prominent anti-bacterial capacities of compounds derived from the mangosteen fruit
45.			A recent update on the antibacterial effects of distinct bioactive molecules derived from the Cannabis plant
46.			A review of the anti-bacterial effects exerted by Aronia melanocarpa
47.			A review of the antimicrobial and immune-modulatory properties of the gut microbiota-derived short chain fatty acid propionate - What is new?
48.			Review of therapeutic options for infections with carbapenem-resistant Klebsiella pneumoniae
49.			The role of gelatinases in Campylobacter jejuni infection of gnotobiotic mice
50.			The Role of IL-23, IL-22, and IL-18 in Campylobacter Jejuni Infection of Conventional Infant Mice

Mind kijelölve: